UPDATE 1-Mylan says merger with Teva would be bad fit
April 17, 2015 at 15:31 PM EDT
April 17 (Reuters) - Generic drugmaker Mylan NV moved quickly on Friday to pour cold water on published reports that Teva Pharmaceuticals Industries is considering a bid to acquire it.
